Locally advanced rectal cancer: Histopathological correlation and predictive accuracy of serial MRI after neoadjuvant chemotherapy

British Journal of Radiology

Volumn 82, Issue 976, 2009, Pages 332-336

  Johnston, D F ^a   Lawrence, K M ^a   Sizer, B F ^b   Arulampalam, T H A ^a   Motson, R W ^a   Dove, E ^c   Lacey, N ^a  

^a O and G   (United Kingdom)

^b ESSEX COUNTY HOSPITAL   (United Kingdom)

^c UNIVERSITY OF ESSEX   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FOLINIC ACID; UFT;

ADJUVANT CHEMOTHERAPY; ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; CORRELATION ANALYSIS; DIAGNOSTIC ACCURACY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT MONITORING; PREDICTION; PREOPERATIVE EVALUATION; RECTUM CARCINOMA; TREATMENT RESPONSE; TUMOR VOLUME;

ADENOCARCINOMA; ADULT; AGED; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOADJUVANT THERAPY; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; RECTAL NEOPLASMS; SENSITIVITY AND SPECIFICITY; TREATMENT OUTCOME;

EID: 65349174613     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/61056525     Document Type: Article

References (11)

1. Mercury Study Group. Diagnostic accuracy of preoperative magnetic resonance imaging in predicting curative resection of rectal cancer: prospective observational study. Br Med J 2006;333:779-881.
2. Brown G, Radcliffe AG, Newcombe RG, Dallimore NS, Bourne MW, Williams GT. Preoperative assessment of prognostic factors in rectal cancer using high-resolution magnetic resonance imaging. Br J Surg 2003;90:355-64.
3. Allen SD, Padhani AR, Dzik-Jurasz AS, Glynne-Jones R. Rectal carcinoma: MRI with histologic correlation before and after chemoradiation therapy. AJR Am J Roentgenol 2007;188:442-51.
4. Kuo LJ, Chern MC, Tsou MH, Liu MC, Jian JJ, Chen CM et al. Interpretation of magnetic resonance imaging for locally advanced rectal carcinoma after preoperative chemoradia-tion therapy. Dis Colon Rectum 2005;48:23-8.
5. Wotherspoon, AC. Pathological assessment of rectal carcinoma after preoperative therapy. Colorectal Dis 2006;8:37-39.
6. Rodel C, Martus P, Papadouploos T, Fuzesi L, Klimpfinger M, Fietkau R et al. Prognostic significance of tumor regression after preoperative chemoradiotherapy for rectal cancer. J Clin Oncol 2005;23:8688-96.
7. Mercury Study Group. Extramural depth of tumour invasion at thin section MR in patients with rectal cancer: results of the MERCURY study. Radiology 2007;243:132-9.
8. Merkel S, Mansmann U, Siassi M, Papadopoulus T, Hohenberger W, Heranek P. The prognostic inhomogeneity in pT3 rectal carcinomas. Int J Colorectal Dis 2001;16:298-304.
9. Brown G, Richards CJ, Newcombe RG, Dallimore NS, Radcliffe AG, Carey DP et al. Rectal carcinoma: thin-section MR imaging for staging in 28 patients. Radiology 1999;211:215-22.
10. Sizer BF, Arulampalam T, Austin R, Lacey N, Menzies D, Motson R. MRI in predicting curative resection of rectal cancer: defining a ''window of opportunity'' for laparo-scopic surgery. BMJ 2006;333:808-9.
11. Sizer B, Arulampalam T, Austin R, Basu D, Lacey N, Menzies D et al. Individualizing the interval between neoadjuvant chemoradiation with uracil-tegafur (UFT) and total mesorectal excision in magnetic resonance imaging (MRI) defined poor-risk rectal cancer. J Clin Oncol, 2007 ASCO Annual Meeting Proceedings Part I. Vol 25, No 18S (June 20 Supplement), 2007:14557.